Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Arcoxia
2. L 791456
3. L-791456
4. L791456
5. Mk 0663
6. Mk-0663
7. Mk0663
1. 202409-33-4
2. Arcoxia
3. Tauxib
4. Nucoxia
5. Algix
6. Mk-0663
7. 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine
8. Mk-663
9. L-791456
10. Mk 0663
11. 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
12. Mk 663
13. 2,3'-bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-
14. 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
15. Wrx4nfy03r
16. L791456
17. 5-chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
18. Chebi:6339
19. Chembl416146
20. 2,3'-bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-
21. 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
22. Ncgc00164578-01
23. Etoricoxibe
24. Etropain
25. Torcoxia
26. Etoxib
27. 5-chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
28. Mk-0663;l-791456
29. Dsstox_cid_26457
30. Dsstox_rid_81631
31. Dsstox_gsid_46457
32. Etoricoxib [usan:inn:ban]
33. Kingcox
34. 5-chloro-6'-methyl-3-(4-(methylsulfonyl)-phenyl)-2,3'-bipyridine
35. Etoricoxib [usan]
36. Cas-202409-33-4
37. Sr-05000001486
38. Etoricoxib (usan/inn)
39. Unii-wrx4nfy03r
40. Mk0663
41. Etoricoxibum
42. Etoricoxib- Bio-x
43. Etoricoxib [mi]
44. Etoricoxib [inn]
45. Etoricoxib [mart.]
46. Schembl4680
47. Etoricoxib [who-dd]
48. Gtpl2896
49. Dtxsid3046457
50. Hms2090a05
51. Hms3713p20
52. Hms3885h14
53. Zinc579472
54. Amy30994
55. Bcp06428
56. Ex-a2642
57. Tox21 112206
58. Tox21_112206
59. Bdbm50072064
60. Etoricoxib; Mk-663; Mk-0663
61. Mfcd06797512
62. S4651
63. Akos016010125
64. Tox21_112206_1
65. Ccg-220639
66. Cs-1047
67. Db01628
68. Sb18988
69. Ncgc00164578-02
70. 5ch
71. Ac-29052
72. As-17761
73. Bc164436
74. Etoricoxib 100 Microg/ml In Acetonitrile
75. Hy-15321
76. Db-045133
77. Ft-0602793
78. Ft-0668437
79. D03710
80. Etoricoxib, Vetranal(tm), Analytical Standard
81. Ab01275483-01
82. 409e334
83. A848896
84. L001141
85. Q631202
86. J-013140
87. Sr-05000001486-1
88. Sr-05000001486-2
89. Brd-k54770957-001-01-9
90. Brd-k54770957-001-02-7
91. L-791,456
92. F2173-0490
93. Etoricoxib, United States Pharmacopeia (usp) Reference Standard
94. 5-chloro-3-(4-methanesulfonyl-phenyl)-6''''-methyl-[2,3'''']bipyridinyl
95. 5-chloro-3-(4-methanesulfonyl-phenyl)-6''-methyl-[2,3'']bipyridinyl
96. 5-chloro-3-(4-methanesulfonylphenyl)-2-(6-methylpyridin-3-yl)pyridine
97. 5-chloro-3-[4-(methylsulfonyl)phenyl]-2-(2-methyl-5-pyridinyl)pyridine
98. 5-chloro-6''-methyl-3-[4-(methylsulfonyl)phenyl]-2,3''-bipyridine
| Molecular Weight | 358.8 g/mol |
|---|---|
| Molecular Formula | C18H15ClN2O2S |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 358.0542766 g/mol |
| Monoisotopic Mass | 358.0542766 g/mol |
| Topological Polar Surface Area | 68.3 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 514 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.
Etoricoxib is a COX-2 selective inhibitor (approximately 106 times more selective for COX-2 inhibition over COX-1).
Cyclooxygenase 2 Inhibitors
A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
M01AH05
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AH - Coxibs
M01AH05 - Etoricoxib
Absorption
Bioavailability is 100% following oral administration.
Hepatic, primarily via CYP3A4.
Etoricoxib has known human metabolites that include 6-Hydroxymethyletoricoxib and Etoricoxib 1'-N'-oxide.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
22 hours
Like any other COX-2 selective inhibitor Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2), preventing production of prostaglandins (PGs) from arachidonic acid.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41843
Submission : 2025-06-24
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34537
Submission : 2020-02-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29951
Submission : 2015-11-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26044
Submission : 2012-05-15
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm : Unit-IV, Plot No: 34B, 40B & 60B, J.N. Pharma City, Thanam (V), Parawada (M), An...
Date of Issue : 2025-08-22
Valid Till : 2028-08-21
Written Confirmation Number : WC-0082
Address of the Firm : Karakhadi, Plot No. 842-843, At - Karakhdi, Tal. - Padra, Dist -Vadodara, Gujara...
Date of Issue : 2025-08-01
Valid Till : 2028-07-02
Written Confirmation Number : WC-0083
Address of the Firm : API Division Il, Survey No. 144P1, 144P2, 144P3, 145P, 137, 138, 139, 140, Panel...
Date of Issue : 2023-11-28
Valid Till : 2026-11-28
Written Confirmation Number : WC-0310
Address of the Firm : Plot No. Z-103/l, Dahej SEZ, Phase II, Dahej, Dist-Bharuch, Gujarat, India
Date of Issue : 2022-07-06
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm : Plot No. 3109, GIDC, Industrial Estate Ankleshwar, Distt- Bharuch - 393002, Guja...
Date of Issue : 2025-05-19
Valid Till : 2028-10-07
Written Confirmation Number : WC-0428
Address of the Firm : Plot No. 23 E, Survey No. 24P & 25P, AP SEZ Denotified Area, Lalamkoduru (V), Ra...
Date of Issue : 2025-09-03
Valid Till : 2028-08-08
Written Confirmation Number : WC-0041
Address of the Firm : Unit-I, Sy. No. 10, I.D.A, Gaddapotharam (V), Jinnaram (M), Sangareddy District,...
Date of Issue : 2022-08-11
Valid Till : 2025-08-15
Written Confirmation Number : WC-0225
Address of the Firm : Plot No. 43 to 45, KIADB, Bommasandra Industrial area, 4th phase, Anekal taluk, ...
Date of Issue : 2025-10-08
Valid Till : 2028-06-26
Written Confirmation Number : WC-0016
Address of the Firm : (Unit-9) Plot No.5, Road No. 12, Jawaharlal Nehru Pharma City, Tadi Village, Par...
Date of Issue : 2025-09-19
Valid Till : 2028-07-27
Written Confirmation Number : WC-0062
Address of the Firm : Plot No. 197, Sector -I, Pithampur -454775, District -Dhar (MP), India.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
Registrant Name : Seongwoo Chemical Co., Ltd.
Registration Date : 2019-05-23
Registration Number : Su473-20-ND
Manufacturer Name : Alembic Pharmaceuticals Limi...
Manufacturer Address : AT-Panelav, Tal-Halol, City : Panelav, Dist : Panchmahal, Gujarat State, India
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2020-07-21
Registration Number : Su473-20-ND(1)
Manufacturer Name : Alembic Pharmaceuticals Limi...
Manufacturer Address : AT-Panelav, Tal-Halol, City : Panelav, Dist : Panchmahal, Gujarat State, India
Registrant Name : Aju Pharmaceutical Co., Ltd.
Registration Date : 2021-10-18
Registration Number : Su55-9-ND(1)
Manufacturer Name : Glenmark Life Sciences Ltd
Manufacturer Address : Plot No.Z-103/ I, DAHEJ SEZ Phase II, City : Dahej, District : Bharuch, Gujarat State...
Registrant Name : Mpeak Korea Co., Ltd.
Registration Date : 2019-04-19
Registration Number : Su55-9-ND
Manufacturer Name : Alivus Life Sciences Limited
Manufacturer Address : Plot No.Z-103/ I, DAHEJ SEZ Phase II, City : Dahej, District : Bharuch, Gujarat State...
Registrant Name : Korea Organon Co., Ltd.
Registration Date : 2014-12-23
Registration Number : Su3281-15-ND
Manufacturer Name : FIS-Fabbrica Italiana Sintet...
Manufacturer Address : Via Massimo D'Antoná 13 Termoli, Campobasso 86039, Italy@Alte - Montecchio Maggiore ...
Registrant Name : Farmia Co., Ltd.
Registration Date : 2020-08-13
Registration Number : Su719-1-ND
Manufacturer Name : Kekule Pharma Limited
Manufacturer Address : Sy. No. 180/1 to 15, MIA Kazipally, Kazipally(V) Jinnaram(M), Sangareddy District-502...
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2019-02-20
Registration Number : Su289-5-ND
Manufacturer Name : Tianish Laboratories Private...
Manufacturer Address : Plot No. 5, Road No.12, JN Pharma City, Tadi Village, Parawada Mandal, Anakapalli Dis...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-006
Start Marketing Date : 2020-01-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0053
Start Marketing Date : 2012-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
With Virupaksha, you get a quality product with on-time delivery.
About the Company : Virupaksha Organics, founded in 2003, is a leading manufacturer of APIs and intermediates. Its FDA-audited, ISO-certified facilities in Kazipally and Pashamylaram produce high-qual...
Axplora is your partner of choice for complex APIs.
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulat...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
About the Company : Nuray Chemicals Pvt Ltd, established in 2012 near Chennai, is an API manufacturer for highly regulated markets. Its state-of-the-art R&D facility specializes in synthesizing NCEs, ...
Emay Pharmaceuticals is a GMP-certified API manufacturing company.
About the Company : Emay Pharmaceuticals Pvt Ltd operates as the merchant export division of M/s. Bhavna Laboratories Pvt Ltd. The company is a GMP-approved API manufacturer with over three decades of...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma is a contract pharmaceutical company based in Gujarat, India, specializing in the manufacturing and marketing of corticosteroids, hormones, antivirals, and oncology p...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of experience in formulation development, manufacturing, and commercialization. Its portfoli...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
Etoricoxib is a Small Molecule drug, which is currently being evaluated in Phase III clinical studies for the treatment of Bursitis.
Lead Product(s): Etoricoxib,Betamethasone
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 08, 2026
Lead Product(s) : Etoricoxib,Betamethasone
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Etoricoxib is a Small Molecule drug, which is currently being evaluated in Phase III clinical studies for the treatment of Bursitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 08, 2026
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.
Lead Product(s): Etoricoxib,Tizanidine Hydrochloride
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 07, 2025
Lead Product(s) : Etoricoxib,Tizanidine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 07, 2025
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Arthritis, Gouty.
Lead Product(s): Etoricoxib,Betamethasone
Therapeutic Area: Rheumatology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 07, 2025
Lead Product(s) : Etoricoxib,Betamethasone
Therapeutic Area : Rheumatology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Arthritis, Gouty.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 07, 2025
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.
Lead Product(s): Etoricoxib,Vitamin B12
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 24, 2024
Lead Product(s) : Etoricoxib,Vitamin B12
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 24, 2024
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acute Pain.
Lead Product(s): Etoricoxib,Tramadol Hydrochloride
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Infinite Clinical Research
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 16, 2023
Lead Product(s) : Etoricoxib,Tramadol Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Infinite Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Acute Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 16, 2023
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Lead Product(s): Etoricoxib,Cyclobenzaprine
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 13, 2023
Lead Product(s) : Etoricoxib,Cyclobenzaprine
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 13, 2023
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Etoricoxib,Tramadol Hydrochloride
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 08, 2022
Lead Product(s) : Etoricoxib,Tramadol Hydrochloride
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 08, 2022
Details:
Duloxetine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis, Knee.
Lead Product(s): Duloxetine Hydrochloride,Etoricoxib,Omeprazole
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 25, 2022
Lead Product(s) : Duloxetine Hydrochloride,Etoricoxib,Omeprazole
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Biomarkers for Prediction of Analgesic Efficacy in Knee OA.
Details : Duloxetine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis, Knee.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 25, 2022
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Etoricoxib,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Anapharm
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 20, 2021
Lead Product(s) : Etoricoxib,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Anapharm
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 20, 2021
Details:
Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Back Pain.
Lead Product(s): Etoricoxib,Tramadol Hydrochloride
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 20, 2021
Lead Product(s) : Etoricoxib,Tramadol Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Etoricoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Back Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 20, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
2-Chloro-1,3-bis(dimethylamino)trimethinium hexafl...
CAS Number : 249561-98-6
End Use API : Etoricoxib
About The Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), p...
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
4-(methyl sulfonyl)-phenyl acetic acid
CAS Number : 90536-66-6
End Use API : Etoricoxib
About The Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), p...
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
CAS Number : 10297-73-1
End Use API : Etoricoxib
About The Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), p...
Oxygenta Pharmaceutical Limited — Powering healthcare through reliable pharmaceuticals and organic fine chemicals
CAS Number : 291756-76-8
End Use API : Etoricoxib
About The Company : Oxygenta Pharmaceutical Limited was incorporated as a private limited company in 1990 and later converted into a limited company in 1993. The company was establ...
Oxygenta Pharmaceutical Limited — Powering healthcare through reliable pharmaceuticals and organic fine chemicals
2-Butyl-4-chloro-5-Formyl-1H-Imidazole(BCFI)
CAS Number : 221615-75-4
End Use API : Etoricoxib
About The Company : Oxygenta Pharmaceutical Limited was incorporated as a private limited company in 1990 and later converted into a limited company in 1993. The company was establ...
4-METHYL SULPHONYLPHENYL ACETIC ACID (4-MSP)
CAS Number : 90536-66-6
End Use API : Etoricoxib
About The Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nat...
CAS Number : 5470-70-2
End Use API : Etoricoxib
About The Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nat...
2-CHLORO-1,3- BIS(DIMENTYAMINO)TRIMETHINIUMHEXAFLU...
CAS Number : 249561-98-6
End Use API : Etoricoxib
About The Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nat...
1-(6-METHYLPYRIDIN-3-YL)-2-[4- (METHYLSULFONYL) PH...
CAS Number : 221615-75-4
End Use API : Etoricoxib
About The Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nat...
2-(4-Methanesulfonyl-phenyl)-1- (6-methyl-pyridin-...
CAS Number : 221615-75-4
End Use API : Etoricoxib
About The Company : Anupam Rasayan India Limited was started in 1976 and we are 36 years old. ISO 9001:2008 and ISO 14001:2004 certified chemical company with sound technology, en...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Etoricoxib Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 24/02/2022
Application Number : 68245
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Etoricoxib Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 60mg
Packaging :
Approval Date : 24/02/2022
Application Number : 68245
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 120mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000056
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 60mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000032
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 90mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000049
Regulatory Info : Approved
Registration Country : Sweden
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Etoricoxib Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 24/02/2022
Application Number : 68245
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Etoricoxib Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 60mg
Packaging :
Approval Date : 24/02/2022
Application Number : 68245
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 120mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000056
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 60mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000032
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Etoricoxib Orion
Dosage Form : Film Coated Tablet
Dosage Strength : 90mg
Packaging :
Approval Date : 02/12/2016
Application Number : 20150807000049
Regulatory Info : Approved
Registration Country : Sweden
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Etoricoxib \"Strides\"
Dosage Form : Film Coated Tablet
Dosage Strength : 120mg
Packaging :
Approval Date : 18-03-2024
Application Number : 28107075623
Regulatory Info : Prescription
Registration Country : Denmark
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Etoricoxib \"Strides\"
Dosage Form : Film Coated Tablet
Dosage Strength : 30mg
Packaging :
Approval Date : 18-03-2024
Application Number : 28107074823
Regulatory Info : Prescription
Registration Country : Denmark
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Etoricoxib \"Strides\"
Dosage Form : Film Coated Tablet
Dosage Strength : 60mg
Packaging :
Approval Date : 18-03-2024
Application Number : 28107075423
Regulatory Info : Prescription
Registration Country : Denmark
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Etoricoxib \"Strides\"
Dosage Form : Film Coated Tablet
Dosage Strength : 90mg
Packaging :
Approval Date : 18-03-2024
Application Number : 28107075523
Regulatory Info : Prescription
Registration Country : Denmark
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Ebov 60 mg
Dosage Form : FCT
Dosage Strength : 60mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Adco Etoricoxib 90 mg
Dosage Form : FCT
Dosage Strength : 90mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Etoricoxib 90mg Austell
Dosage Form : FCT
Dosage Strength : 90mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : ETORICOXIB 90 BIOTECH
Dosage Form : FCT
Dosage Strength : 90mg
Packaging : 7X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : ETORICOXIB 120 BIOTECH
Dosage Form : FCT
Dosage Strength : 120mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rumator 120mg
Dosage Form : TAB
Dosage Strength : 120mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Arcoxia
Dosage Form : TAB
Dosage Strength : 60mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : CORICIB 90 mg
Dosage Form : FCT
Dosage Strength : 90mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : THRYTIX 90
Dosage Form : FCT
Dosage Strength : 90mg
Packaging : 7X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Maracoxa 120
Dosage Form : FCT
Dosage Strength : 120mg
Packaging : 7X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : DC Granules
Dosage Strength : 30MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : DC Granules
Dosage Strength : 60MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : DC Granules
Dosage Strength : 90MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : DC Granules
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : DC Granules
Dosage Strength : 120MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : Tablet
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 60MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : Tablet
Dosage Strength : 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 90MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : Tablet
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 120MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 30MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : Tablet
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 60MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Etoricoxib
Dosage Form : Tablet
Dosage Strength : 90MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 90MG
Brand Name : Etoricoxib
Approval Date :
Application Number :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
22 Nov 2025
Reply
27 Oct 2025
Reply
28 Mar 2025
Reply
28 Nov 2024
Reply
14 Nov 2024
Reply
17 Sep 2024
Reply
03 Jan 2024
Reply
25 Oct 2023
Reply
29 Sep 2023
Reply
09 Jun 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EXCIPIENTS
Reply
08 Aug 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
34
PharmaCompass offers a list of Etoricoxib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Etoricoxib manufacturer or Etoricoxib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Etoricoxib manufacturer or Etoricoxib supplier.
PharmaCompass also assists you with knowing the Etoricoxib API Price utilized in the formulation of products. Etoricoxib API Price is not always fixed or binding as the Etoricoxib Price is obtained through a variety of data sources. The Etoricoxib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Algix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Algix, including repackagers and relabelers. The FDA regulates Algix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Algix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Algix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Algix supplier is an individual or a company that provides Algix active pharmaceutical ingredient (API) or Algix finished formulations upon request. The Algix suppliers may include Algix API manufacturers, exporters, distributors and traders.
click here to find a list of Algix suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Algix DMF (Drug Master File) is a document detailing the whole manufacturing process of Algix active pharmaceutical ingredient (API) in detail. Different forms of Algix DMFs exist exist since differing nations have different regulations, such as Algix USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Algix DMF submitted to regulatory agencies in the US is known as a USDMF. Algix USDMF includes data on Algix's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Algix USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Algix suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Algix Drug Master File in Korea (Algix KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Algix. The MFDS reviews the Algix KDMF as part of the drug registration process and uses the information provided in the Algix KDMF to evaluate the safety and efficacy of the drug.
After submitting a Algix KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Algix API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Algix suppliers with KDMF on PharmaCompass.
A Algix written confirmation (Algix WC) is an official document issued by a regulatory agency to a Algix manufacturer, verifying that the manufacturing facility of a Algix active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Algix APIs or Algix finished pharmaceutical products to another nation, regulatory agencies frequently require a Algix WC (written confirmation) as part of the regulatory process.
click here to find a list of Algix suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Algix as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Algix API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Algix as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Algix and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Algix NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Algix suppliers with NDC on PharmaCompass.
Algix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Algix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Algix GMP manufacturer or Algix GMP API supplier for your needs.
A Algix CoA (Certificate of Analysis) is a formal document that attests to Algix's compliance with Algix specifications and serves as a tool for batch-level quality control.
Algix CoA mostly includes findings from lab analyses of a specific batch. For each Algix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Algix may be tested according to a variety of international standards, such as European Pharmacopoeia (Algix EP), Algix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Algix USP).
Comment (8)
